Yuhan Corporation (KRX:000100) Shares Could Be 20% Below Their Intrinsic Value Estimate
Aug 31
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Healthcare Sector Analysis
UpdatedSep 06, 2025
DataAggregated Company Financials
Companies368
- 7D4.0%
- 3M9.7%
- 1Y14.2%
- YTD15.4%
Over the last 7 days, the Healthcare industry has risen 4.0%, driven by gains in Samsung BiologicsLtd and ALTEOGEN of 2.9% and 8.4%, respectively. In the same time, PharmaResearch was down 7.4%. This means that the industry has gained 14% over the past year. As for the next few years, earnings are expected to grow by 32% per annum.
Sector Valuation and Performance
Has the South Korean Healthcare Sector valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 07 Sep 2025 | ₩301.0t | ₩60.0t | ₩1.9t | 21.5x | 156.2x | 5x |
| Tue, 05 Aug 2025 | ₩289.9t | ₩58.4t | ₩1.4t | 21.4x | 200.9x | 5x |
| Thu, 03 Jul 2025 | ₩279.0t | ₩58.0t | ₩1.5t | 21.4x | 188.5x | 4.8x |
| Sat, 31 May 2025 | ₩272.5t | ₩57.6t | ₩1.5t | 22.1x | 183.9x | 4.7x |
| Mon, 28 Apr 2025 | ₩267.2t | ₩56.1t | ₩1.4t | 18.5x | 195.9x | 4.8x |
| Wed, 26 Mar 2025 | ₩271.6t | ₩56.1t | ₩1.1t | 14.3x | 256.9x | 4.8x |
| Fri, 21 Feb 2025 | ₩281.4t | ₩54.7t | ₩897.3b | 15.5x | 313.6x | 5.1x |
| Sun, 19 Jan 2025 | ₩264.0t | ₩54.5t | ₩828.4b | 14.8x | 318.7x | 4.8x |
| Tue, 17 Dec 2024 | ₩261.8t | ₩49.6t | ₩1.0t | 13.8x | 253x | 5.3x |
| Thu, 14 Nov 2024 | ₩252.0t | ₩53.1t | ₩814.8b | 14.1x | 309.3x | 4.7x |
| Sat, 12 Oct 2024 | ₩278.5t | ₩53.3t | ₩854.8b | 16.2x | 325.8x | 5.2x |
| Mon, 09 Sep 2024 | ₩256.3t | ₩53.4t | ₩856.5b | 16.3x | 299.3x | 4.8x |
| Wed, 07 Aug 2024 | ₩243.2t | ₩52.3t | ₩750.8b | 15.2x | 323.9x | 4.7x |
| Fri, 05 Jul 2024 | ₩235.4t | ₩52.3t | ₩749.4b | 16.2x | 314.2x | 4.5x |
| Sun, 02 Jun 2024 | ₩219.8t | ₩53.0t | ₩713.1b | 16.3x | 308.3x | 4.2x |
| Tue, 30 Apr 2024 | ₩234.1t | ₩52.3t | ₩538.5b | 18.2x | 434.8x | 4.5x |
| Thu, 28 Mar 2024 | ₩246.9t | ₩52.6t | ₩486.1b | 20.2x | 507.9x | 4.7x |
| Sat, 24 Feb 2024 | ₩228.6t | ₩52.0t | -₩48,458,490,006.00 | 23x | -4717.4x | 4.4x |
| Mon, 22 Jan 2024 | ₩230.7t | ₩55.7t | ₩55.5b | 23x | 4159.2x | 4.1x |
| Wed, 20 Dec 2023 | ₩216.7t | ₩56.1t | ₩280.7b | 21.5x | 772.2x | 3.9x |
| Fri, 17 Nov 2023 | ₩208.8t | ₩56.0t | ₩1.0t | 19.1x | 204.5x | 3.7x |
| Sun, 15 Oct 2023 | ₩204.8t | ₩56.0t | ₩1.0t | 18.7x | 200.1x | 3.7x |
| Tue, 12 Sep 2023 | ₩220.2t | ₩56.0t | ₩930.7b | 20.7x | 236.5x | 3.9x |
| Thu, 10 Aug 2023 | ₩222.0t | ₩56.1t | ₩2.1t | 23.1x | 106.2x | 4x |
| Sat, 08 Jul 2023 | ₩199.1t | ₩56.1t | ₩2.1t | 20x | 94.6x | 3.5x |
| Mon, 05 Jun 2023 | ₩219.1t | ₩56.3t | ₩2.1t | 21.1x | 103.9x | 3.9x |
| Wed, 03 May 2023 | ₩210.8t | ₩58.4t | ₩3.2t | 20.4x | 64.9x | 3.6x |
| Fri, 31 Mar 2023 | ₩201.6t | ₩58.2t | ₩3.4t | 19.7x | 58.5x | 3.5x |
| Sun, 26 Feb 2023 | ₩201.1t | ₩57.8t | ₩4.6t | 19.4x | 43.7x | 3.5x |
| Tue, 24 Jan 2023 | ₩203.8t | ₩57.8t | ₩4.6t | 17.4x | 44.2x | 3.5x |
| Thu, 22 Dec 2022 | ₩210.3t | ₩57.5t | ₩3.9t | 16.4x | 54.2x | 3.7x |
| Sat, 19 Nov 2022 | ₩215.1t | ₩56.7t | ₩4.0t | 15.9x | 54x | 3.8x |
| Mon, 17 Oct 2022 | ₩192.2t | ₩55.7t | ₩4.1t | 14.9x | 47.2x | 3.4x |
| Wed, 14 Sep 2022 | ₩211.0t | ₩56.0t | ₩4.2t | 17.5x | 49.8x | 3.8x |
Price to Earnings Ratio
49.8x
Current Industry PE
- Investors are pessimistic on the South Korean Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 156x which is lower than its 3-year average PE of 265x.
- The 3-year average PS ratio of 4.3x is lower than the industry's current PS ratio of 5.0x.
Past Earnings Growth
- The earnings for companies in the Healthcare industry have declined 23% per year over the last three years.
- Meanwhile revenues for these companies have grown 2.3% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare sector?
| KR Market | 0.74% | |
| Healthcare | 3.99% | |
| Healthtech | 5.86% | |
| Biotech | 4.89% | |
| Medical Equipment | 4.50% | |
| Pharma | 4.27% | |
| Life Sciences | 2.63% | |
| Healthcare Services | 0.11% | |
Industry PE
- Investors are most optimistic about the Medical Equipment industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 37.0%, which is higher than its past year's earnings decline of 2.1% per year.
Forecasted Growth
- Analysts are most optimistic on the Healthtech industry, expecting annual earnings growth of 67% over the next 5 years.
- This is better than its past earnings decline of 3.3% per year.
- In contrast, the Life Sciences industry is expected to see its earnings grow by 20% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A207940 Samsung BiologicsLtd | ₩1.03m | 2.9% +₩2.1t | 6.7% | PE57x | |
| A196170 ALTEOGEN | ₩475.50k | 8.4% +₩2.0t | 58.0% | PE269.5x | |
| A326030 SK Biopharmaceuticals | ₩109.20k | 10.8% +₩830.1b | 4.9% | PE33.4x | |
| A298380 ABL Bio | ₩103.00k | 12.4% +₩622.2b | 256.4% | PS59.2x | |
| A226950 OliX Pharmaceuticals | ₩88.70k | 43.5% +₩543.1b | 419.9% | PS236.6x |
